Delivery Order SPE2DB25D3012-SPE2DB26FWVQM
- Not listed
- The Defense Logistics Agency awarded a $2,511.19 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,080.98 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 27, 2025, with completion scheduled for August 28, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.33 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-tablet units) on September 19, 2025, with completion scheduled for September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The pharmaceutical will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,710.30 for Vemlidy 25 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, valued at $4,584.29. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitive procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) at a ceiling value of $3,346.62. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for ultimate completion by October 21, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $8,731.21 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on October 24, 2025, with completion expected by October 27, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement typical of pharmaceutical supply transactions under the DLA's medical procurement framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, with a ceiling value of $11,313.60. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, leveraging AmerisourceBergen's...
- The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price contract with no set-aside designation, competitively awarded under an existing indefinite delivery vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $3,649.19. This non-set-aside delivery order, with an ultimate completion date of August 29, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery supporting federal medical...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVQMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,832.55 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count unit) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. AmerisourceBergen's position as a major pharmaceutical distributor and critical vendor for federal medical procurement is reinforced through its established track record of fulfilling diverse pharmaceutical deliveries ranging from generic medications to specialty drugs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 10/27/25 |